Through you, Chair, to the clerk, to break this logjam.... I understand Mr. Bigras' reservations, and we don't want to see the baby tossed out with the bathwater, if you will, but I'd ask him if the changes that have happened that he is worried about in regard to admissibility are because we are using the Food and Drugs Act as opposed to CEPA, which was the original design of the bill. Is that where the contentious point of admissibility is?
Maybe I could have some clarification.